D04AB01 lidocaine

DERMATOLOGICALS ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. Anesthetics for topical use

健保收載品項 TFDA 在效許可證 11 FDA 已核准 健保給付條款 2

台灣藥品與外觀

台灣食藥署在效西藥許可證 11 張;以下列出 11 個品項。

健保收載品名:"人人" 利度凝膠2%(鹽酸利度卡因)、"意欣"利多卡因貼片5%、"真富"剋疼貼片、利度卡因2%無菌外用凝膠、強力施美藥膏、美帝貼片5%、美膚健藥膏、苦息樂卡因凍膠、苦息樂軟膏、遠疼貼貼片 5%

無外觀照
苦息樂卡因唧筒式噴霧劑10%
無外觀照
"人人" 利度凝膠2%(鹽酸利度卡因)
無外觀照
愛寶凝膠2%(鹽酸利卡因)
無外觀照
"長安"卡多力凝膠2%(鹽酸利度卡因)
無外觀照
"井田"力多凝膠2%(鹽酸利度卡困)
無外觀照
利得凝膠
無外觀照
遠疼貼貼片 5%
無外觀照
本卡因2%凝膠(鹽酸利度卡因)
無外觀照
美帝貼片5%
無外觀照
"意欣"利多卡因貼片5%
無外觀照
"真富"剋疼貼片

資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。

適應症

台灣 TFDA 核准適應症

  1. 對粘膜具有潤滑、局部麻醉和消毒作用。
  2. 用於緩解皰疹後神經痛(Post-herpeticNeuralgia)。使用部位僅限於未受損的皮膚。
  3. 局部麻醉。
  4. 表面麻醉。

美國 FDA 適應症(英文原文對照)

美國 FDA 核准成分 lidocaine 4%, menthol 1% (商品名 0.5% LIDOCAINE BURN RELIEF / 1168 / Absorbine Jr Pro Cream / Accucaine / Alocane Botanicals / Alocane Emergency Burn) · 仿單更新 2026-04-16

Drug Facts Active ingredients: Lidocaine 4% Menthol 1% Purpose Topical anesthetic - Topical analgesic INDICATIONS & USAGE Uses: For temporary relief of pain. Warnings For external use only DO NOT USE Do not use: More than one patch on your body at a time - On wounds or damaged skin - For more than one week without consulting a doctor - If you are allergic to any ingredients of this product. WHEN USING When using this product: Use only as directed - Avoid contact with the eyes, mucous membranes or rashes - Do not bandage tightly STOP USE Stop use and consult a doctor if: Localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering - Conditions worsen - Symptoms persist for more than 7 ... PREGNANCY OR BREAST FEEDING If pregnant or breastfeeding: Ask a health professional before use. KEEP OUT OF REACH OF CHILDREN Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away. DOSAGE & ADMINISTRATION Directions: Adults, or children over the age of 12: Clean and dry affected area. Remove film from patch and apply to skin (see illustration). Apply one patch at a time to affected area, not more ... Other Information: Store at 68 °F-77° F (20 °C-25° C.) Store in a clean, dry place without direct sunlight. Inactive Ingredients: Dihydroxyaluminum Aminoacetate, Edetate Disodium, Glycerin, Hydroxyacetophenone, Kaolin, L(+)-Tartaric Acid, Mineral Oil, Polysorbate 80, Polyacrylic Acid, Polyvinylpyrroliodone K90, Propylene ... QUESTIONS ​Questions or Comments: 833.711.8833 - [email protected] PRINCIPAL DISPLAY PANEL NDC 82944-104-10 - LIDOSYNC - Lidocaine 4% Menthol 1% TOPICAL PAIN PATCH - For Temporary Pain Relief - Flexible Patch Innovation - Soothing and Effective - Long Lasting Relief - 10 FLEXIBLE ... INGREDIENTS AND APPEARANCE Product Information Uses: For temporary relief of pain.

資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。

健保給付規定

直接適用條款

§ 13.8 Tazarotene外用製劑:(91/4/1、99/12/1、101/2/1)
皮膚科製劑 › Tazarotene 外用製劑:(91/4/1、99/12/1、101/2/1)
Tazarotene外用製劑:(91/4/1、99/12/1、101/2/1)
1.限乾癬之病例使用。
2.使用量以每星期不高於30gm為原則。若因病情需要,使用量需超過每星期30gm者,應於病歷詳細記載理由。(99/12/1)
3.與calcitriol (或calcipotriol)併用,兩者合計總量每星期不超過30gm或30mL,若因病情需要兩者合併使用量需超過每星期30gm者,應於病歷詳細記載理由。(99/12/1)
歷史演變(3 次異動)
生效日異動說明
91/4/1legacy_boan_parsed:ch13.txt
99/12/1legacy_boan_parsed:ch13.txt
101/2/1legacy_boan_parsed:ch13.txt
§ 13.9 Calcitriol (如Silkis ointment):(92/11/1、93/9/1、99/12/1)
皮膚科製劑 › Calcitriol (如Silkis ointment):(92/11/1、93/9/1、99/12/1)
Calcitriol (如Silkis ointment):(92/11/1、93/9/1、99/12/1)
1.限用於小於35%體表面積之輕度至中重度乾癬之病例,使用量以每星期不高於30gm為原則,若因病情需要使用量需超過每星期30gm者,應於病歷詳細記錄理由。其面積計算:依照rule of nines計算法。(同13.10備註1)
2.與tazarotene併用,兩者合計總量每星期不超過30gm或30mL,若因病情需要兩者合併使用量需超過每星期30gm者,應於病歷詳細記錄理由。(99/12/1)
歷史演變(3 次異動)
生效日異動說明
92/11/1legacy_boan_parsed:ch13.txt
93/9/1legacy_boan_parsed:ch13.txt
99/12/1legacy_boan_parsed:ch13.txt

實證補充

本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。


台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。